nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCB1—Mitomycin—stomach cancer	0.106	0.148	CbGbCtD
Apixaban—ABCG2—Irinotecan—stomach cancer	0.0756	0.105	CbGbCtD
Apixaban—ABCG2—Fluorouracil—stomach cancer	0.0725	0.101	CbGbCtD
Apixaban—ABCG2—Docetaxel—stomach cancer	0.0554	0.0771	CbGbCtD
Apixaban—CYP2C9—Capecitabine—stomach cancer	0.0454	0.0633	CbGbCtD
Apixaban—CYP3A5—Irinotecan—stomach cancer	0.0419	0.0583	CbGbCtD
Apixaban—ABCG2—Doxorubicin—stomach cancer	0.0413	0.0575	CbGbCtD
Apixaban—ABCG2—Methotrexate—stomach cancer	0.04	0.0557	CbGbCtD
Apixaban—CYP2C8—Fluorouracil—stomach cancer	0.0386	0.0538	CbGbCtD
Apixaban—CYP3A5—Docetaxel—stomach cancer	0.0307	0.0427	CbGbCtD
Apixaban—CYP1A2—Fluorouracil—stomach cancer	0.0299	0.0416	CbGbCtD
Apixaban—ABCB1—Irinotecan—stomach cancer	0.0272	0.0379	CbGbCtD
Apixaban—CYP2C9—Fluorouracil—stomach cancer	0.0269	0.0375	CbGbCtD
Apixaban—ABCB1—Docetaxel—stomach cancer	0.02	0.0278	CbGbCtD
Apixaban—CYP3A4—Irinotecan—stomach cancer	0.0163	0.0227	CbGbCtD
Apixaban—ABCB1—Doxorubicin—stomach cancer	0.0149	0.0207	CbGbCtD
Apixaban—ABCB1—Methotrexate—stomach cancer	0.0144	0.0201	CbGbCtD
Apixaban—CYP3A4—Docetaxel—stomach cancer	0.012	0.0167	CbGbCtD
Apixaban—CYP3A4—Doxorubicin—stomach cancer	0.00892	0.0124	CbGbCtD
Apixaban—CYP2J2—blood vessel—stomach cancer	0.00451	0.133	CbGeAlD
Apixaban—F10—hematopoietic system—stomach cancer	0.00293	0.0861	CbGeAlD
Apixaban—F10—endocrine gland—stomach cancer	0.00168	0.0495	CbGeAlD
Apixaban—F10—liver—stomach cancer	0.00152	0.0446	CbGeAlD
Apixaban—CYP2J2—endocrine gland—stomach cancer	0.00138	0.0406	CbGeAlD
Apixaban—CYP2J2—liver—stomach cancer	0.00124	0.0366	CbGeAlD
Apixaban—F10—lymph node—stomach cancer	0.00116	0.0342	CbGeAlD
Apixaban—Haematemesis—Capecitabine—stomach cancer	0.00108	0.00847	CcSEcCtD
Apixaban—CYP2C19—hematopoietic system—stomach cancer	0.00107	0.0315	CbGeAlD
Apixaban—Metrorrhagia—Capecitabine—stomach cancer	0.00105	0.00824	CcSEcCtD
Apixaban—Anaemia—Mitomycin—stomach cancer	0.00104	0.00818	CcSEcCtD
Apixaban—Vaginal haemorrhage—Capecitabine—stomach cancer	0.00101	0.00795	CcSEcCtD
Apixaban—Haemoptysis—Capecitabine—stomach cancer	0.00101	0.00795	CcSEcCtD
Apixaban—Syncope—Mitomycin—stomach cancer	0.00101	0.00794	CcSEcCtD
Apixaban—Loss of consciousness—Mitomycin—stomach cancer	0.00099	0.00778	CcSEcCtD
Apixaban—CYP2C8—hematopoietic system—stomach cancer	0.000937	0.0275	CbGeAlD
Apixaban—Blood alkaline phosphatase increased—Irinotecan—stomach cancer	0.000934	0.00734	CcSEcCtD
Apixaban—Gingival bleeding—Epirubicin—stomach cancer	0.00092	0.00722	CcSEcCtD
Apixaban—Petechiae—Capecitabine—stomach cancer	0.000911	0.00715	CcSEcCtD
Apixaban—Shock—Mitomycin—stomach cancer	0.000905	0.00711	CcSEcCtD
Apixaban—Thrombocytopenia—Mitomycin—stomach cancer	0.0009	0.00707	CcSEcCtD
Apixaban—CYP1A2—hematopoietic system—stomach cancer	0.000877	0.0258	CbGeAlD
Apixaban—Hypersensitivity—Floxuridine—stomach cancer	0.000863	0.00678	CcSEcCtD
Apixaban—Contusion—Capecitabine—stomach cancer	0.000859	0.00674	CcSEcCtD
Apixaban—Transaminases increased—Epirubicin—stomach cancer	0.000858	0.00674	CcSEcCtD
Apixaban—Gingival bleeding—Doxorubicin—stomach cancer	0.000851	0.00668	CcSEcCtD
Apixaban—CYP3A5—hematopoietic system—stomach cancer	0.000846	0.0248	CbGeAlD
Apixaban—ABCB1—blood vessel—stomach cancer	0.000844	0.0248	CbGeAlD
Apixaban—CYP2C9—hematopoietic system—stomach cancer	0.000832	0.0244	CbGeAlD
Apixaban—Rectal haemorrhage—Capecitabine—stomach cancer	0.00083	0.00651	CcSEcCtD
Apixaban—Blood bilirubin increased—Docetaxel—stomach cancer	0.000818	0.00643	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Irinotecan—stomach cancer	0.000813	0.00638	CcSEcCtD
Apixaban—Haematemesis—Methotrexate—stomach cancer	0.000803	0.00631	CcSEcCtD
Apixaban—Transaminases increased—Doxorubicin—stomach cancer	0.000794	0.00623	CcSEcCtD
Apixaban—Blood bilirubin increased—Capecitabine—stomach cancer	0.000792	0.00622	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Fluorouracil—stomach cancer	0.000778	0.00611	CcSEcCtD
Apixaban—Haematemesis—Epirubicin—stomach cancer	0.000751	0.0059	CcSEcCtD
Apixaban—CYP2C19—digestive system—stomach cancer	0.000746	0.0219	CbGeAlD
Apixaban—Rash—Floxuridine—stomach cancer	0.000739	0.0058	CcSEcCtD
Apixaban—Dermatitis—Floxuridine—stomach cancer	0.000738	0.0058	CcSEcCtD
Apixaban—Melaena—Capecitabine—stomach cancer	0.000732	0.00575	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Irinotecan—stomach cancer	0.000732	0.00575	CcSEcCtD
Apixaban—Haemoptysis—Epirubicin—stomach cancer	0.000705	0.00554	CcSEcCtD
Apixaban—Vaginal haemorrhage—Epirubicin—stomach cancer	0.000705	0.00554	CcSEcCtD
Apixaban—Nausea—Floxuridine—stomach cancer	0.000696	0.00547	CcSEcCtD
Apixaban—Haematemesis—Doxorubicin—stomach cancer	0.000695	0.00546	CcSEcCtD
Apixaban—CYP3A5—pancreas—stomach cancer	0.000689	0.0202	CbGeAlD
Apixaban—Petechiae—Methotrexate—stomach cancer	0.000678	0.00532	CcSEcCtD
Apixaban—Ecchymosis—Capecitabine—stomach cancer	0.000677	0.00532	CcSEcCtD
Apixaban—Haemoptysis—Doxorubicin—stomach cancer	0.000653	0.00512	CcSEcCtD
Apixaban—Vaginal haemorrhage—Doxorubicin—stomach cancer	0.000653	0.00512	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Docetaxel—stomach cancer	0.000646	0.00507	CcSEcCtD
Apixaban—CYP3A4—hematopoietic system—stomach cancer	0.000635	0.0186	CbGeAlD
Apixaban—Petechiae—Epirubicin—stomach cancer	0.000634	0.00498	CcSEcCtD
Apixaban—Diabetes mellitus—Capecitabine—stomach cancer	0.000625	0.00491	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Capecitabine—stomach cancer	0.000625	0.00491	CcSEcCtD
Apixaban—CYP2C19—endocrine gland—stomach cancer	0.000617	0.0181	CbGeAlD
Apixaban—CYP1A2—digestive system—stomach cancer	0.00061	0.0179	CbGeAlD
Apixaban—Dizziness—Mitomycin—stomach cancer	0.000608	0.00478	CcSEcCtD
Apixaban—CYP3A5—digestive system—stomach cancer	0.000588	0.0173	CbGeAlD
Apixaban—Petechiae—Doxorubicin—stomach cancer	0.000587	0.00461	CcSEcCtD
Apixaban—ABCG2—bone marrow—stomach cancer	0.000584	0.0172	CbGeAlD
Apixaban—Rash—Mitomycin—stomach cancer	0.00058	0.00455	CcSEcCtD
Apixaban—Dermatitis—Mitomycin—stomach cancer	0.000579	0.00455	CcSEcCtD
Apixaban—CYP2C9—digestive system—stomach cancer	0.000579	0.017	CbGeAlD
Apixaban—Rectal haemorrhage—Epirubicin—stomach cancer	0.000578	0.00454	CcSEcCtD
Apixaban—Epistaxis—Fluorouracil—stomach cancer	0.000566	0.00444	CcSEcCtD
Apixaban—Haemoglobin—Irinotecan—stomach cancer	0.000565	0.00444	CcSEcCtD
Apixaban—Haemorrhage—Irinotecan—stomach cancer	0.000562	0.00442	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Docetaxel—stomach cancer	0.000562	0.00441	CcSEcCtD
Apixaban—CYP2C19—liver—stomach cancer	0.000556	0.0163	CbGeAlD
Apixaban—Connective tissue disorder—Irinotecan—stomach cancer	0.000552	0.00434	CcSEcCtD
Apixaban—Blood bilirubin increased—Epirubicin—stomach cancer	0.000552	0.00433	CcSEcCtD
Apixaban—Nausea—Mitomycin—stomach cancer	0.000546	0.00429	CcSEcCtD
Apixaban—Melaena—Methotrexate—stomach cancer	0.000545	0.00428	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Capecitabine—stomach cancer	0.000544	0.00427	CcSEcCtD
Apixaban—Haemoglobin—Fluorouracil—stomach cancer	0.000541	0.00425	CcSEcCtD
Apixaban—Haemorrhage—Fluorouracil—stomach cancer	0.000538	0.00423	CcSEcCtD
Apixaban—CYP2C8—endocrine gland—stomach cancer	0.000538	0.0158	CbGeAlD
Apixaban—Rectal haemorrhage—Doxorubicin—stomach cancer	0.000535	0.0042	CcSEcCtD
Apixaban—Liver function test abnormal—Docetaxel—stomach cancer	0.000519	0.00407	CcSEcCtD
Apixaban—Blood bilirubin increased—Doxorubicin—stomach cancer	0.000511	0.00401	CcSEcCtD
Apixaban—Angiopathy—Irinotecan—stomach cancer	0.00051	0.00401	CcSEcCtD
Apixaban—Melaena—Epirubicin—stomach cancer	0.00051	0.004	CcSEcCtD
Apixaban—Immune system disorder—Irinotecan—stomach cancer	0.000508	0.00399	CcSEcCtD
Apixaban—Breast disorder—Docetaxel—stomach cancer	0.000508	0.00399	CcSEcCtD
Apixaban—Mediastinal disorder—Irinotecan—stomach cancer	0.000507	0.00398	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Docetaxel—stomach cancer	0.000506	0.00397	CcSEcCtD
Apixaban—Ecchymosis—Methotrexate—stomach cancer	0.000504	0.00396	CcSEcCtD
Apixaban—CYP1A2—endocrine gland—stomach cancer	0.000504	0.0148	CbGeAlD
Apixaban—Liver function test abnormal—Capecitabine—stomach cancer	0.000502	0.00394	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Docetaxel—stomach cancer	0.000495	0.00389	CcSEcCtD
Apixaban—Breast disorder—Capecitabine—stomach cancer	0.000491	0.00386	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Capecitabine—stomach cancer	0.00049	0.00385	CcSEcCtD
Apixaban—CYP3A5—endocrine gland—stomach cancer	0.000486	0.0143	CbGeAlD
Apixaban—CYP2C8—liver—stomach cancer	0.000485	0.0143	CbGeAlD
Apixaban—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.00048	0.00377	CcSEcCtD
Apixaban—CYP2C9—endocrine gland—stomach cancer	0.000478	0.014	CbGeAlD
Apixaban—ABCG2—liver—stomach cancer	0.000472	0.0139	CbGeAlD
Apixaban—Ecchymosis—Epirubicin—stomach cancer	0.000472	0.00371	CcSEcCtD
Apixaban—Melaena—Doxorubicin—stomach cancer	0.000472	0.00371	CcSEcCtD
Apixaban—Diabetes mellitus—Methotrexate—stomach cancer	0.000465	0.00366	CcSEcCtD
Apixaban—CYP1A2—liver—stomach cancer	0.000454	0.0133	CbGeAlD
Apixaban—Anaemia—Irinotecan—stomach cancer	0.000452	0.00355	CcSEcCtD
Apixaban—ABCB1—hematopoietic system—stomach cancer	0.000449	0.0132	CbGeAlD
Apixaban—CYP3A4—digestive system—stomach cancer	0.000441	0.013	CbGeAlD
Apixaban—Syncope—Irinotecan—stomach cancer	0.000439	0.00345	CcSEcCtD
Apixaban—CYP3A5—liver—stomach cancer	0.000438	0.0129	CbGeAlD
Apixaban—Ecchymosis—Doxorubicin—stomach cancer	0.000437	0.00343	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Epirubicin—stomach cancer	0.000436	0.00342	CcSEcCtD
Apixaban—Diabetes mellitus—Epirubicin—stomach cancer	0.000436	0.00342	CcSEcCtD
Apixaban—Anaemia—Fluorouracil—stomach cancer	0.000433	0.0034	CcSEcCtD
Apixaban—CYP2C9—liver—stomach cancer	0.000431	0.0127	CbGeAlD
Apixaban—Loss of consciousness—Irinotecan—stomach cancer	0.00043	0.00338	CcSEcCtD
Apixaban—ABCB1—epithelium—stomach cancer	0.000411	0.0121	CbGeAlD
Apixaban—Hepatobiliary disease—Docetaxel—stomach cancer	0.000409	0.00322	CcSEcCtD
Apixaban—Epistaxis—Docetaxel—stomach cancer	0.000408	0.00321	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Doxorubicin—stomach cancer	0.000403	0.00317	CcSEcCtD
Apixaban—Diabetes mellitus—Doxorubicin—stomach cancer	0.000403	0.00317	CcSEcCtD
Apixaban—Haematuria—Capecitabine—stomach cancer	0.0004	0.00314	CcSEcCtD
Apixaban—Anaphylactic shock—Irinotecan—stomach cancer	0.000399	0.00314	CcSEcCtD
Apixaban—Hepatobiliary disease—Capecitabine—stomach cancer	0.000396	0.00311	CcSEcCtD
Apixaban—Epistaxis—Capecitabine—stomach cancer	0.000395	0.0031	CcSEcCtD
Apixaban—Shock—Irinotecan—stomach cancer	0.000393	0.00309	CcSEcCtD
Apixaban—Nervous system disorder—Irinotecan—stomach cancer	0.000392	0.00308	CcSEcCtD
Apixaban—Thrombocytopenia—Irinotecan—stomach cancer	0.000391	0.00307	CcSEcCtD
Apixaban—Haemoglobin—Docetaxel—stomach cancer	0.000391	0.00307	CcSEcCtD
Apixaban—Haemorrhage—Docetaxel—stomach cancer	0.000389	0.00305	CcSEcCtD
Apixaban—Urinary tract disorder—Docetaxel—stomach cancer	0.000384	0.00301	CcSEcCtD
Apixaban—Anaphylactic shock—Fluorouracil—stomach cancer	0.000383	0.003	CcSEcCtD
Apixaban—Connective tissue disorder—Docetaxel—stomach cancer	0.000382	0.003	CcSEcCtD
Apixaban—Urethral disorder—Docetaxel—stomach cancer	0.000381	0.00299	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Epirubicin—stomach cancer	0.000379	0.00298	CcSEcCtD
Apixaban—Haemoglobin—Capecitabine—stomach cancer	0.000378	0.00297	CcSEcCtD
Apixaban—Haemorrhage—Capecitabine—stomach cancer	0.000376	0.00296	CcSEcCtD
Apixaban—Nervous system disorder—Fluorouracil—stomach cancer	0.000375	0.00295	CcSEcCtD
Apixaban—Thrombocytopenia—Fluorouracil—stomach cancer	0.000375	0.00294	CcSEcCtD
Apixaban—Liver function test abnormal—Methotrexate—stomach cancer	0.000374	0.00294	CcSEcCtD
Apixaban—Hypotension—Irinotecan—stomach cancer	0.000373	0.00293	CcSEcCtD
Apixaban—Urinary tract disorder—Capecitabine—stomach cancer	0.000372	0.00292	CcSEcCtD
Apixaban—Connective tissue disorder—Capecitabine—stomach cancer	0.00037	0.0029	CcSEcCtD
Apixaban—Urethral disorder—Capecitabine—stomach cancer	0.000369	0.0029	CcSEcCtD
Apixaban—Breast disorder—Methotrexate—stomach cancer	0.000366	0.00287	CcSEcCtD
Apixaban—ABCB1—pancreas—stomach cancer	0.000366	0.0107	CbGeAlD
Apixaban—CYP3A4—endocrine gland—stomach cancer	0.000365	0.0107	CbGeAlD
Apixaban—Eye disorder—Docetaxel—stomach cancer	0.000363	0.00285	CcSEcCtD
Apixaban—ABCG2—lymph node—stomach cancer	0.000362	0.0106	CbGeAlD
Apixaban—Hypotension—Fluorouracil—stomach cancer	0.000357	0.00281	CcSEcCtD
Apixaban—Angiopathy—Docetaxel—stomach cancer	0.000353	0.00277	CcSEcCtD
Apixaban—Eye disorder—Capecitabine—stomach cancer	0.000352	0.00276	CcSEcCtD
Apixaban—Immune system disorder—Docetaxel—stomach cancer	0.000351	0.00276	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Doxorubicin—stomach cancer	0.000351	0.00275	CcSEcCtD
Apixaban—Mediastinal disorder—Docetaxel—stomach cancer	0.00035	0.00275	CcSEcCtD
Apixaban—Liver function test abnormal—Epirubicin—stomach cancer	0.00035	0.00275	CcSEcCtD
Apixaban—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000345	0.00271	CcSEcCtD
Apixaban—Breast disorder—Epirubicin—stomach cancer	0.000342	0.00269	CcSEcCtD
Apixaban—Angiopathy—Capecitabine—stomach cancer	0.000341	0.00268	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.000341	0.00268	CcSEcCtD
Apixaban—Immune system disorder—Capecitabine—stomach cancer	0.00034	0.00267	CcSEcCtD
Apixaban—Mediastinal disorder—Capecitabine—stomach cancer	0.000339	0.00266	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000334	0.00262	CcSEcCtD
Apixaban—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00033	0.00259	CcSEcCtD
Apixaban—CYP3A4—liver—stomach cancer	0.000329	0.00966	CbGeAlD
Apixaban—Liver function test abnormal—Doxorubicin—stomach cancer	0.000324	0.00254	CcSEcCtD
Apixaban—Breast disorder—Doxorubicin—stomach cancer	0.000317	0.00249	CcSEcCtD
Apixaban—ABCB1—lymphoid tissue—stomach cancer	0.000316	0.00929	CbGeAlD
Apixaban—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000316	0.00248	CcSEcCtD
Apixaban—Anaemia—Docetaxel—stomach cancer	0.000313	0.00246	CcSEcCtD
Apixaban—ABCB1—digestive system—stomach cancer	0.000312	0.00918	CbGeAlD
Apixaban—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000309	0.00243	CcSEcCtD
Apixaban—Syncope—Docetaxel—stomach cancer	0.000303	0.00238	CcSEcCtD
Apixaban—Anaemia—Capecitabine—stomach cancer	0.000303	0.00238	CcSEcCtD
Apixaban—Haematuria—Methotrexate—stomach cancer	0.000297	0.00234	CcSEcCtD
Apixaban—Loss of consciousness—Docetaxel—stomach cancer	0.000297	0.00234	CcSEcCtD
Apixaban—Hepatobiliary disease—Methotrexate—stomach cancer	0.000295	0.00232	CcSEcCtD
Apixaban—Epistaxis—Methotrexate—stomach cancer	0.000294	0.00231	CcSEcCtD
Apixaban—Hypersensitivity—Irinotecan—stomach cancer	0.000294	0.00231	CcSEcCtD
Apixaban—Syncope—Capecitabine—stomach cancer	0.000294	0.00231	CcSEcCtD
Apixaban—ABCB1—bone marrow—stomach cancer	0.000288	0.00846	CbGeAlD
Apixaban—Loss of consciousness—Capecitabine—stomach cancer	0.000288	0.00226	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000286	0.00225	CcSEcCtD
Apixaban—Hypersensitivity—Fluorouracil—stomach cancer	0.000282	0.00221	CcSEcCtD
Apixaban—Haemoglobin—Methotrexate—stomach cancer	0.000282	0.00221	CcSEcCtD
Apixaban—Haemorrhage—Methotrexate—stomach cancer	0.00028	0.0022	CcSEcCtD
Apixaban—Haematuria—Epirubicin—stomach cancer	0.000278	0.00219	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000277	0.00217	CcSEcCtD
Apixaban—Urinary tract disorder—Methotrexate—stomach cancer	0.000277	0.00217	CcSEcCtD
Apixaban—Hepatobiliary disease—Epirubicin—stomach cancer	0.000276	0.00217	CcSEcCtD
Apixaban—Anaphylactic shock—Docetaxel—stomach cancer	0.000276	0.00217	CcSEcCtD
Apixaban—Epistaxis—Epirubicin—stomach cancer	0.000275	0.00216	CcSEcCtD
Apixaban—Urethral disorder—Methotrexate—stomach cancer	0.000275	0.00216	CcSEcCtD
Apixaban—Shock—Docetaxel—stomach cancer	0.000272	0.00213	CcSEcCtD
Apixaban—Nervous system disorder—Docetaxel—stomach cancer	0.000271	0.00213	CcSEcCtD
Apixaban—Thrombocytopenia—Docetaxel—stomach cancer	0.00027	0.00212	CcSEcCtD
Apixaban—Skin disorder—Docetaxel—stomach cancer	0.000268	0.00211	CcSEcCtD
Apixaban—Dizziness—Irinotecan—stomach cancer	0.000264	0.00207	CcSEcCtD
Apixaban—Haemoglobin—Epirubicin—stomach cancer	0.000263	0.00207	CcSEcCtD
Apixaban—Shock—Capecitabine—stomach cancer	0.000263	0.00207	CcSEcCtD
Apixaban—Nervous system disorder—Capecitabine—stomach cancer	0.000262	0.00206	CcSEcCtD
Apixaban—Haemorrhage—Epirubicin—stomach cancer	0.000262	0.00206	CcSEcCtD
Apixaban—Eye disorder—Methotrexate—stomach cancer	0.000262	0.00206	CcSEcCtD
Apixaban—Thrombocytopenia—Capecitabine—stomach cancer	0.000262	0.00206	CcSEcCtD
Apixaban—Skin disorder—Capecitabine—stomach cancer	0.00026	0.00204	CcSEcCtD
Apixaban—Urinary tract disorder—Epirubicin—stomach cancer	0.000259	0.00203	CcSEcCtD
Apixaban—ABCB1—endocrine gland—stomach cancer	0.000258	0.00758	CbGeAlD
Apixaban—Hypotension—Docetaxel—stomach cancer	0.000258	0.00203	CcSEcCtD
Apixaban—Haematuria—Doxorubicin—stomach cancer	0.000258	0.00202	CcSEcCtD
Apixaban—Connective tissue disorder—Epirubicin—stomach cancer	0.000258	0.00202	CcSEcCtD
Apixaban—Urethral disorder—Epirubicin—stomach cancer	0.000257	0.00202	CcSEcCtD
Apixaban—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000256	0.00201	CcSEcCtD
Apixaban—Epistaxis—Doxorubicin—stomach cancer	0.000255	0.002	CcSEcCtD
Apixaban—Angiopathy—Methotrexate—stomach cancer	0.000254	0.002	CcSEcCtD
Apixaban—Immune system disorder—Methotrexate—stomach cancer	0.000253	0.00199	CcSEcCtD
Apixaban—Dizziness—Fluorouracil—stomach cancer	0.000253	0.00199	CcSEcCtD
Apixaban—Mediastinal disorder—Methotrexate—stomach cancer	0.000252	0.00198	CcSEcCtD
Apixaban—Rash—Irinotecan—stomach cancer	0.000252	0.00198	CcSEcCtD
Apixaban—Dermatitis—Irinotecan—stomach cancer	0.000252	0.00198	CcSEcCtD
Apixaban—Hypotension—Capecitabine—stomach cancer	0.00025	0.00196	CcSEcCtD
Apixaban—Eye disorder—Epirubicin—stomach cancer	0.000245	0.00192	CcSEcCtD
Apixaban—Haemoglobin—Doxorubicin—stomach cancer	0.000244	0.00191	CcSEcCtD
Apixaban—Haemorrhage—Doxorubicin—stomach cancer	0.000243	0.0019	CcSEcCtD
Apixaban—Rash—Fluorouracil—stomach cancer	0.000241	0.00189	CcSEcCtD
Apixaban—Dermatitis—Fluorouracil—stomach cancer	0.000241	0.00189	CcSEcCtD
Apixaban—Urinary tract disorder—Doxorubicin—stomach cancer	0.00024	0.00188	CcSEcCtD
Apixaban—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000238	0.00187	CcSEcCtD
Apixaban—Connective tissue disorder—Doxorubicin—stomach cancer	0.000238	0.00187	CcSEcCtD
Apixaban—Angiopathy—Epirubicin—stomach cancer	0.000238	0.00187	CcSEcCtD
Apixaban—Urethral disorder—Doxorubicin—stomach cancer	0.000238	0.00187	CcSEcCtD
Apixaban—Nausea—Irinotecan—stomach cancer	0.000237	0.00186	CcSEcCtD
Apixaban—Immune system disorder—Epirubicin—stomach cancer	0.000237	0.00186	CcSEcCtD
Apixaban—Mediastinal disorder—Epirubicin—stomach cancer	0.000236	0.00186	CcSEcCtD
Apixaban—ABCB1—liver—stomach cancer	0.000233	0.00684	CbGeAlD
Apixaban—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000231	0.00181	CcSEcCtD
Apixaban—Nausea—Fluorouracil—stomach cancer	0.000227	0.00178	CcSEcCtD
Apixaban—Eye disorder—Doxorubicin—stomach cancer	0.000227	0.00178	CcSEcCtD
Apixaban—Anaemia—Methotrexate—stomach cancer	0.000225	0.00177	CcSEcCtD
Apixaban—Angiopathy—Doxorubicin—stomach cancer	0.00022	0.00173	CcSEcCtD
Apixaban—Immune system disorder—Doxorubicin—stomach cancer	0.000219	0.00172	CcSEcCtD
Apixaban—Mediastinal disorder—Doxorubicin—stomach cancer	0.000219	0.00172	CcSEcCtD
Apixaban—Anaemia—Epirubicin—stomach cancer	0.000211	0.00166	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000206	0.00162	CcSEcCtD
Apixaban—Syncope—Epirubicin—stomach cancer	0.000205	0.00161	CcSEcCtD
Apixaban—Hypersensitivity—Docetaxel—stomach cancer	0.000203	0.0016	CcSEcCtD
Apixaban—Loss of consciousness—Epirubicin—stomach cancer	0.000201	0.00158	CcSEcCtD
Apixaban—Anaphylactic shock—Methotrexate—stomach cancer	0.000199	0.00156	CcSEcCtD
Apixaban—Hypersensitivity—Capecitabine—stomach cancer	0.000197	0.00155	CcSEcCtD
Apixaban—Nervous system disorder—Methotrexate—stomach cancer	0.000195	0.00153	CcSEcCtD
Apixaban—Anaemia—Doxorubicin—stomach cancer	0.000195	0.00153	CcSEcCtD
Apixaban—Thrombocytopenia—Methotrexate—stomach cancer	0.000195	0.00153	CcSEcCtD
Apixaban—Skin disorder—Methotrexate—stomach cancer	0.000193	0.00152	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000193	0.00152	CcSEcCtD
Apixaban—Syncope—Doxorubicin—stomach cancer	0.000189	0.00149	CcSEcCtD
Apixaban—Anaphylactic shock—Epirubicin—stomach cancer	0.000186	0.00146	CcSEcCtD
Apixaban—Hypotension—Methotrexate—stomach cancer	0.000186	0.00146	CcSEcCtD
Apixaban—Loss of consciousness—Doxorubicin—stomach cancer	0.000186	0.00146	CcSEcCtD
Apixaban—Shock—Epirubicin—stomach cancer	0.000183	0.00144	CcSEcCtD
Apixaban—Nervous system disorder—Epirubicin—stomach cancer	0.000183	0.00143	CcSEcCtD
Apixaban—Dizziness—Docetaxel—stomach cancer	0.000183	0.00143	CcSEcCtD
Apixaban—Thrombocytopenia—Epirubicin—stomach cancer	0.000182	0.00143	CcSEcCtD
Apixaban—Skin disorder—Epirubicin—stomach cancer	0.000181	0.00142	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000179	0.0014	CcSEcCtD
Apixaban—ABCB1—lymph node—stomach cancer	0.000178	0.00524	CbGeAlD
Apixaban—Dizziness—Capecitabine—stomach cancer	0.000177	0.00139	CcSEcCtD
Apixaban—Rash—Docetaxel—stomach cancer	0.000174	0.00137	CcSEcCtD
Apixaban—Hypotension—Epirubicin—stomach cancer	0.000174	0.00137	CcSEcCtD
Apixaban—Dermatitis—Docetaxel—stomach cancer	0.000174	0.00137	CcSEcCtD
Apixaban—Anaphylactic shock—Doxorubicin—stomach cancer	0.000172	0.00135	CcSEcCtD
Apixaban—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000172	0.00135	CcSEcCtD
Apixaban—Shock—Doxorubicin—stomach cancer	0.00017	0.00133	CcSEcCtD
Apixaban—Nervous system disorder—Doxorubicin—stomach cancer	0.000169	0.00133	CcSEcCtD
Apixaban—Thrombocytopenia—Doxorubicin—stomach cancer	0.000169	0.00133	CcSEcCtD
Apixaban—Rash—Capecitabine—stomach cancer	0.000169	0.00132	CcSEcCtD
Apixaban—Dermatitis—Capecitabine—stomach cancer	0.000168	0.00132	CcSEcCtD
Apixaban—Skin disorder—Doxorubicin—stomach cancer	0.000167	0.00131	CcSEcCtD
Apixaban—Nausea—Docetaxel—stomach cancer	0.000164	0.00129	CcSEcCtD
Apixaban—Hypotension—Doxorubicin—stomach cancer	0.000161	0.00126	CcSEcCtD
Apixaban—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000161	0.00126	CcSEcCtD
Apixaban—Nausea—Capecitabine—stomach cancer	0.000159	0.00125	CcSEcCtD
Apixaban—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000149	0.00117	CcSEcCtD
Apixaban—Hypersensitivity—Methotrexate—stomach cancer	0.000147	0.00115	CcSEcCtD
Apixaban—Hypersensitivity—Epirubicin—stomach cancer	0.000137	0.00108	CcSEcCtD
Apixaban—Dizziness—Methotrexate—stomach cancer	0.000132	0.00103	CcSEcCtD
Apixaban—Hypersensitivity—Doxorubicin—stomach cancer	0.000127	0.000997	CcSEcCtD
Apixaban—Rash—Methotrexate—stomach cancer	0.000125	0.000985	CcSEcCtD
Apixaban—Dermatitis—Methotrexate—stomach cancer	0.000125	0.000984	CcSEcCtD
Apixaban—Dizziness—Epirubicin—stomach cancer	0.000123	0.000967	CcSEcCtD
Apixaban—Nausea—Methotrexate—stomach cancer	0.000118	0.000928	CcSEcCtD
Apixaban—Rash—Epirubicin—stomach cancer	0.000117	0.000922	CcSEcCtD
Apixaban—Dermatitis—Epirubicin—stomach cancer	0.000117	0.000921	CcSEcCtD
Apixaban—Dizziness—Doxorubicin—stomach cancer	0.000114	0.000895	CcSEcCtD
Apixaban—Nausea—Epirubicin—stomach cancer	0.000111	0.000869	CcSEcCtD
Apixaban—Rash—Doxorubicin—stomach cancer	0.000109	0.000853	CcSEcCtD
Apixaban—Dermatitis—Doxorubicin—stomach cancer	0.000109	0.000852	CcSEcCtD
Apixaban—Nausea—Doxorubicin—stomach cancer	0.000102	0.000804	CcSEcCtD
Apixaban—CYP2C8—Metabolism—RORA—stomach cancer	2.18e-05	0.000181	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PLIN2—stomach cancer	2.17e-05	0.00018	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—DPYD—stomach cancer	2.16e-05	0.00018	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CA2—stomach cancer	2.11e-05	0.000175	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—FADS1—stomach cancer	2.11e-05	0.000175	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—TYMP—stomach cancer	2.11e-05	0.000175	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.11e-05	0.000175	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PGLS—stomach cancer	2.09e-05	0.000174	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—BLVRB—stomach cancer	2.09e-05	0.000174	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	2.08e-05	0.000172	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—FADS1—stomach cancer	2.06e-05	0.000171	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—TYMP—stomach cancer	2.06e-05	0.000171	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NT5E—stomach cancer	2.05e-05	0.000171	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PGAM1—stomach cancer	2.05e-05	0.000171	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALDOB—stomach cancer	2.05e-05	0.00017	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PDHA1—stomach cancer	2.04e-05	0.00017	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ECHS1—stomach cancer	2.04e-05	0.00017	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.02e-05	0.000168	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPAP2A—stomach cancer	2e-05	0.000166	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.97e-05	0.000164	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.97e-05	0.000164	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SREBF2—stomach cancer	1.97e-05	0.000164	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALDH7A1—stomach cancer	1.96e-05	0.000163	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PLCE1—stomach cancer	1.96e-05	0.000163	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—RORA—stomach cancer	1.95e-05	0.000162	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.93e-05	0.00016	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SREBF2—stomach cancer	1.93e-05	0.00016	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.93e-05	0.00016	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—TYMP—stomach cancer	1.92e-05	0.00016	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—FADS1—stomach cancer	1.92e-05	0.00016	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTT1—stomach cancer	1.91e-05	0.000159	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—RORA—stomach cancer	1.9e-05	0.000158	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALOX5—stomach cancer	1.9e-05	0.000158	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP2A6—stomach cancer	1.89e-05	0.000157	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPP2R1A—stomach cancer	1.89e-05	0.000157	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.88e-05	0.000156	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—UMPS—stomach cancer	1.88e-05	0.000156	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—DPYD—stomach cancer	1.87e-05	0.000155	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.87e-05	0.000155	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTP1—stomach cancer	1.85e-05	0.000154	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKR1C3—stomach cancer	1.84e-05	0.000153	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALDOB—stomach cancer	1.83e-05	0.000152	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—HMOX1—stomach cancer	1.82e-05	0.000151	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SREBF2—stomach cancer	1.8e-05	0.000149	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ENO1—stomach cancer	1.79e-05	0.000149	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALDOB—stomach cancer	1.78e-05	0.000148	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—FBP1—stomach cancer	1.78e-05	0.000148	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.78e-05	0.000148	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CA1—stomach cancer	1.78e-05	0.000148	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CKB—stomach cancer	1.78e-05	0.000148	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—RORA—stomach cancer	1.78e-05	0.000148	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PDHA1—stomach cancer	1.75e-05	0.000145	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ECHS1—stomach cancer	1.75e-05	0.000145	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.72e-05	0.000143	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—TYMS—stomach cancer	1.72e-05	0.000143	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.72e-05	0.000143	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.71e-05	0.000142	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTM1—stomach cancer	1.7e-05	0.000141	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALOX5—stomach cancer	1.7e-05	0.000141	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.7e-05	0.000141	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLIN2—stomach cancer	1.67e-05	0.000139	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—DPYD—stomach cancer	1.67e-05	0.000139	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALDOB—stomach cancer	1.67e-05	0.000138	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALOX5—stomach cancer	1.66e-05	0.000138	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.66e-05	0.000138	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTT1—stomach cancer	1.66e-05	0.000137	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TYMP—stomach cancer	1.64e-05	0.000136	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—FADS1—stomach cancer	1.64e-05	0.000136	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP2A6—stomach cancer	1.64e-05	0.000136	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—DPYD—stomach cancer	1.63e-05	0.000135	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CA2—stomach cancer	1.63e-05	0.000135	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ERCC2—stomach cancer	1.6e-05	0.000133	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.6e-05	0.000132	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKR1C3—stomach cancer	1.59e-05	0.000132	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CD44—stomach cancer	1.59e-05	0.000132	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NT5E—stomach cancer	1.59e-05	0.000132	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PGAM1—stomach cancer	1.59e-05	0.000132	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.57e-05	0.00013	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.57e-05	0.00013	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ENO1—stomach cancer	1.55e-05	0.000129	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALOX5—stomach cancer	1.55e-05	0.000129	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SREBF2—stomach cancer	1.54e-05	0.000128	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.53e-05	0.000127	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—DPYD—stomach cancer	1.52e-05	0.000127	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—RORA—stomach cancer	1.52e-05	0.000126	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.51e-05	0.000126	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.51e-05	0.000126	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLCE1—stomach cancer	1.51e-05	0.000126	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—MTHFR—stomach cancer	1.5e-05	0.000125	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTT1—stomach cancer	1.48e-05	0.000123	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PIK3CA—stomach cancer	1.47e-05	0.000122	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP2A6—stomach cancer	1.46e-05	0.000121	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—UMPS—stomach cancer	1.45e-05	0.00012	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTT1—stomach cancer	1.44e-05	0.00012	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP2A6—stomach cancer	1.43e-05	0.000118	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALDOB—stomach cancer	1.42e-05	0.000118	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKR1C3—stomach cancer	1.42e-05	0.000118	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKR1C3—stomach cancer	1.39e-05	0.000115	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CAV1—stomach cancer	1.39e-05	0.000115	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ENO1—stomach cancer	1.38e-05	0.000115	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—APOA1—stomach cancer	1.38e-05	0.000115	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.38e-05	0.000115	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CD44—stomach cancer	1.38e-05	0.000114	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.36e-05	0.000113	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ENO1—stomach cancer	1.35e-05	0.000112	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPP2R1A—stomach cancer	1.35e-05	0.000112	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ECHS1—stomach cancer	1.35e-05	0.000112	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PDHA1—stomach cancer	1.35e-05	0.000112	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTT1—stomach cancer	1.35e-05	0.000112	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.34e-05	0.000111	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.34e-05	0.000111	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.34e-05	0.000111	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP2A6—stomach cancer	1.33e-05	0.000111	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTP1—stomach cancer	1.33e-05	0.00011	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALOX5—stomach cancer	1.32e-05	0.00011	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—HMOX1—stomach cancer	1.31e-05	0.000109	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—DPYD—stomach cancer	1.3e-05	0.000108	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKR1C3—stomach cancer	1.3e-05	0.000108	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TYMP—stomach cancer	1.27e-05	0.000105	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—FADS1—stomach cancer	1.27e-05	0.000105	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.26e-05	0.000105	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ENO1—stomach cancer	1.26e-05	0.000105	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.24e-05	0.000103	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—TYMS—stomach cancer	1.23e-05	0.000102	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CD44—stomach cancer	1.23e-05	0.000102	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPARG—stomach cancer	1.22e-05	0.000101	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTM1—stomach cancer	1.22e-05	0.000101	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CD44—stomach cancer	1.2e-05	9.95e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.19e-05	9.9e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SREBF2—stomach cancer	1.19e-05	9.85e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.18e-05	9.8e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—RORA—stomach cancer	1.17e-05	9.74e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPP2R1A—stomach cancer	1.17e-05	9.72e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTT1—stomach cancer	1.15e-05	9.56e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTP1—stomach cancer	1.15e-05	9.53e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ERCC2—stomach cancer	1.14e-05	9.51e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP2A6—stomach cancer	1.14e-05	9.45e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HMOX1—stomach cancer	1.13e-05	9.4e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CD44—stomach cancer	1.12e-05	9.3e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKR1C3—stomach cancer	1.11e-05	9.19e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALDOB—stomach cancer	1.1e-05	9.12e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALB—stomach cancer	1.1e-05	9.09e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.09e-05	9.02e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ENO1—stomach cancer	1.08e-05	8.96e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—MTHFR—stomach cancer	1.08e-05	8.94e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—TYMS—stomach cancer	1.07e-05	8.86e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.06e-05	8.81e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTM1—stomach cancer	1.05e-05	8.76e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NOS3—stomach cancer	1.05e-05	8.7e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPP2R1A—stomach cancer	1.04e-05	8.67e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTP1—stomach cancer	1.02e-05	8.51e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALOX5—stomach cancer	1.02e-05	8.48e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.02e-05	8.46e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HMOX1—stomach cancer	1.01e-05	8.39e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—DPYD—stomach cancer	1.01e-05	8.35e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTP1—stomach cancer	1e-05	8.3e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CAV1—stomach cancer	9.93e-06	8.24e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ERCC2—stomach cancer	9.92e-06	8.23e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APOA1—stomach cancer	9.9e-06	8.22e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HMOX1—stomach cancer	9.86e-06	8.19e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—stomach cancer	9.58e-06	7.96e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CD44—stomach cancer	9.57e-06	7.95e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—TYMS—stomach cancer	9.52e-06	7.91e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPP2R1A—stomach cancer	9.52e-06	7.91e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTM1—stomach cancer	9.41e-06	7.82e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTP1—stomach cancer	9.34e-06	7.76e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—MTHFR—stomach cancer	9.32e-06	7.74e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—TYMS—stomach cancer	9.3e-06	7.72e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.29e-06	7.71e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HMOX1—stomach cancer	9.21e-06	7.65e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTM1—stomach cancer	9.19e-06	7.63e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTT1—stomach cancer	8.89e-06	7.38e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ERCC2—stomach cancer	8.85e-06	7.35e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP2A6—stomach cancer	8.78e-06	7.29e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPARG—stomach cancer	8.73e-06	7.25e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—TYMS—stomach cancer	8.68e-06	7.21e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ERCC2—stomach cancer	8.64e-06	7.17e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CAV1—stomach cancer	8.6e-06	7.14e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTM1—stomach cancer	8.58e-06	7.13e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOA1—stomach cancer	8.58e-06	7.12e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKR1C3—stomach cancer	8.55e-06	7.1e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ENO1—stomach cancer	8.33e-06	6.92e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MTHFR—stomach cancer	8.32e-06	6.91e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.21e-06	6.82e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPP2R1A—stomach cancer	8.14e-06	6.76e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MTHFR—stomach cancer	8.12e-06	6.74e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ERCC2—stomach cancer	8.07e-06	6.7e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTP1—stomach cancer	7.98e-06	6.63e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HMOX1—stomach cancer	7.87e-06	6.54e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALB—stomach cancer	7.85e-06	6.52e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CAV1—stomach cancer	7.67e-06	6.37e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOA1—stomach cancer	7.66e-06	6.36e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MTHFR—stomach cancer	7.59e-06	6.3e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARG—stomach cancer	7.56e-06	6.28e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NOS3—stomach cancer	7.51e-06	6.23e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CAV1—stomach cancer	7.49e-06	6.22e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOA1—stomach cancer	7.47e-06	6.21e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TYMS—stomach cancer	7.42e-06	6.16e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CD44—stomach cancer	7.39e-06	6.13e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTM1—stomach cancer	7.34e-06	6.09e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.33e-06	6.09e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CAV1—stomach cancer	7e-06	5.81e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOA1—stomach cancer	6.98e-06	5.8e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ERCC2—stomach cancer	6.9e-06	5.73e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—stomach cancer	6.86e-06	5.7e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALB—stomach cancer	6.8e-06	5.64e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARG—stomach cancer	6.75e-06	5.6e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.69e-06	5.55e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARG—stomach cancer	6.58e-06	5.47e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NOS3—stomach cancer	6.5e-06	5.4e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTHFR—stomach cancer	6.48e-06	5.38e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPP2R1A—stomach cancer	6.28e-06	5.21e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTP1—stomach cancer	6.16e-06	5.12e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARG—stomach cancer	6.15e-06	5.11e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMOX1—stomach cancer	6.08e-06	5.04e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALB—stomach cancer	6.07e-06	5.04e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CAV1—stomach cancer	5.98e-06	4.97e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOA1—stomach cancer	5.97e-06	4.95e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—stomach cancer	5.95e-06	4.94e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALB—stomach cancer	5.92e-06	4.92e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CA—stomach cancer	5.89e-06	4.89e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NOS3—stomach cancer	5.8e-06	4.82e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TYMS—stomach cancer	5.73e-06	4.76e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.71e-06	4.74e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NOS3—stomach cancer	5.66e-06	4.7e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTM1—stomach cancer	5.66e-06	4.7e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALB—stomach cancer	5.53e-06	4.59e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ERCC2—stomach cancer	5.32e-06	4.42e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—stomach cancer	5.31e-06	4.41e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NOS3—stomach cancer	5.29e-06	4.39e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARG—stomach cancer	5.26e-06	4.36e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—stomach cancer	5.18e-06	4.3e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTHFR—stomach cancer	5e-06	4.15e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—stomach cancer	4.84e-06	4.02e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALB—stomach cancer	4.73e-06	3.92e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CAV1—stomach cancer	4.61e-06	3.83e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOA1—stomach cancer	4.6e-06	3.82e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NOS3—stomach cancer	4.52e-06	3.75e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CA—stomach cancer	4.22e-06	3.51e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—stomach cancer	4.14e-06	3.43e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARG—stomach cancer	4.06e-06	3.37e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CA—stomach cancer	3.66e-06	3.04e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALB—stomach cancer	3.65e-06	3.03e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NOS3—stomach cancer	3.49e-06	2.9e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CA—stomach cancer	3.27e-06	2.71e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—stomach cancer	3.19e-06	2.65e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CA—stomach cancer	3.19e-06	2.65e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CA—stomach cancer	2.98e-06	2.47e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CA—stomach cancer	2.54e-06	2.11e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.96e-06	1.63e-05	CbGpPWpGaD
